The prevalence of mitochondrial mutations associated with aminoglycoside-induced deafness in ethnic Latvian population: the appraisal of the evidence

[1]  C. Lanvers-Kaminsky,et al.  Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin. , 2017, Pharmacogenomics.

[2]  Chunlei Liu,et al.  ClinVar: improving access to variant interpretations and supporting evidence , 2017, Nucleic Acids Res..

[3]  P. Steyger,et al.  Aminoglycoside-Induced Cochleotoxicity: A Review , 2017, Front. Cell. Neurosci..

[4]  M. Hallman,et al.  Mitochondrial hearing loss mutations among Finnish preterm and term-born infants , 2017, Audiology research.

[5]  Julia M. Barbarino,et al.  PharmGKB summary: very important pharmacogene information for MT-RNR1 , 2016, Pharmacogenetics and genomics.

[6]  E. Sartorato,et al.  Analysis of mitochondrial alterations in Brazilian patients with sensorineural hearing loss using MALDI-TOF mass spectrometry , 2016, BMC Medical Genetics.

[7]  Yongli Guo,et al.  Deafness gene mutations in newborns in Beijing , 2016, Acta oto-laryngologica.

[8]  M. Guan,et al.  Mitochondrial haplogroup B increases the risk for hearing loss among the Eastern Asian pedigrees carrying 12S rRNA 1555A>G mutation , 2015, Protein & Cell.

[9]  B. Westerberg,et al.  A meta-analysis and systematic review of the prevalence of mitochondrially encoded 12S RNA in the general population: Is there a role for screening neonates requiring aminoglycosides? , 2015, African journal of paediatric surgery : AJPS.

[10]  V. Baumanis,et al.  Genotypic and phenotypic characteristics of aminoglycoside-resistant Mycobacterium tuberculosis isolates in Latvia. , 2015, Diagnostic microbiology and infectious disease.

[11]  S. Nishio,et al.  Frequency of mitochondrial mutations in non-syndromic hearing loss as well as possibly responsible variants found by whole mitochondrial genome screening , 2014, Journal of Human Genetics.

[12]  S. Volinia,et al.  Association between idiopathic hearing loss and mitochondrial DNA mutations: A study on 169 hearing-impaired subjects , 2013, International journal of molecular medicine.

[13]  D. Messineo,et al.  Audiological and radiological characteristics of a family with T961G mitochondrial mutation , 2012, International journal of audiology.

[14]  D. Strachan,et al.  Hearing in 44–45 year olds with m.1555A>G, a genetic mutation predisposing to aminoglycoside-induced deafness: a population based cohort study , 2012, BMJ Open.

[15]  K. Lynch,et al.  The prevalence of mitochondrial mutations associated with aminoglycoside‐induced sensorineural hearing loss in an NICU population , 2011, The Laryngoscope.

[16]  Ronghua Li,et al.  Mitochondrial 12S rRNA variants in 1642 Han Chinese pediatric subjects with aminoglycoside-induced and nonsyndromic hearing loss. , 2010, Mitochondrion.

[17]  R. Płoski,et al.  Mutation analysis of mitochondrial 12S rRNA gene in Polish patients with non-syndromic and aminoglycoside-induced hearing loss. , 2010, Biochemical and biophysical research communications.

[18]  Mariana Postal,et al.  Mutação mitocondrial C1494T, deficiência auditiva e uso de antibióticos aminoglicosídeos , 2009 .

[19]  E. Sartorato,et al.  C1494T mitochondrial dna mutation, hearing loss, and aminoglycosides antibiotics , 2009, Brazilian journal of otorhinolaryngology.

[20]  O. Posukh,et al.  Analysis of mitochondrial 12S rRNA and tRNASer(UCN) genes in patients with nonsyndromic sensorineural hearing loss from various regions of Russia , 2009, Russian Journal of Genetics.

[21]  M. Rydzanicz,et al.  Screening of the general Polish population for deafness-associated mutations in mitochondrial 12S rRNA and tRNA Ser(UCN) genes. , 2009, Genetic testing and molecular biomarkers.

[22]  Manfred Kayser,et al.  Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation , 2009, Human mutation.

[23]  L. Gravina,et al.  Carrier frequency of the 35delG and A1555G deafness mutations in the Argentinean population. Impact on the newborn hearing screening. , 2007, International journal of pediatric otorhinolaryngology.

[24]  X. Bu,et al.  Maternally inherited non-syndromic hearing loss associated with mitochondrial 12S rRNA A827G mutation in a Chinese family. , 2006, Biochemical and biophysical research communications.

[25]  X. Estivill,et al.  Cochlear alterations in deaf and unaffected subjects carrying the deafness-associated A1555G mutation in the mitochondrial 12S rRNA gene. , 2006, Biochemical and biophysical research communications.

[26]  M. Guan.  Mitochondrial 12S rRNA mutations associated with aminoglycoside ototoxicity. , 2005, Mitochondrion.

[27]  R. Villems,et al.  Mitochondrial DNA Portrait of Latvians: Towards the Understanding of the Genetic Structure of Baltic‐Speaking Populations , 2005, Annals of human genetics.

[28]  Selena E. Heman-Ackah,et al.  Mutational analysis of the mitochondrial 12S rRNA gene in Chinese pediatric subjects with aminoglycoside-induced and non-syndromic hearing loss , 2005, Human Genetics.

[29]  D. Choo,et al.  Molecular analysis of the mitochondrial 12S rRNA and tRNASer(UCN) genes in paediatric subjects with non-syndromic hearing loss , 2004, Journal of Medical Genetics.

[30]  J. Finsterer.  Mitochondriopathies , 2004, European journal of neurology.

[31]  Hui Zhao,et al.  Maternally inherited aminoglycoside-induced and nonsyndromic deafness is associated with the novel C1494T mutation in the mitochondrial 12S rRNA gene in a large Chinese family. , 2004, American journal of human genetics.

[32]  M. Speer,et al.  Genetic susceptibility to aminoglycoside ototoxicity: How many are at risk? , 2002, Genetics in Medicine.

[33]  S. Dimauro,et al.  A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy , 2000, Annals of neurology.

[34]  S. Komune,et al.  Prevalence of mitochondrial gene mutations among hearing impaired patients , 2000, Journal of medical genetics.

[35]  X. Estivill,et al.  The A1555G mutation in the 12S rRNA gene of human mtDNA: recurrent origins and founder events in families affected by sensorineural deafness. , 1999, American journal of human genetics.

[36]  W. Tate,et al.  The frequency in New Zealand of a mitochondrial DNA mutation (1555 A to G) associated with aminoglycoside-induced hearing loss. , 1999, The New Zealand medical journal.

[37]  W. Kimberling,et al.  Genetic and Clinical Features of Sensorineural Hearing Loss Associated With the 1555 Mitochondrial Mutation , 1997, The Laryngoscope.

[38]  A. Torroni,et al.  Classification of European mtDNAs from an analysis of three European populations. , 1996, Genetics.

[39]  Mordechai Shohat,et al.  Mitochondrial ribosomal RNA mutation associated with both antibiotic–induced and non–syndromic deafness , 1993, Nature Genetics.

[40]  K. Higashi.  Unique inheritance of streptomycininduced deafness , 1989 .

[41]  Hinshaw Hc,et al.  Auditory Ototoxicity in Tuberculosis Patients Treated with Dihydrostreptomycin: A Report of the Incidence of Hearing Loss in a Series of 1,150 Cases , 1963 .

[42]  E. Zimmerman,et al.  Ototoxicity in preterm infants: effects of genetics, aminoglycosides, and loud environmental noise , 2013, Journal of Perinatology.

[43]  M. Kester.  4 – Treatment of Infectious Diseases , 2012 .

[44]  Ronghua Li,et al.  Mitochondrial haplotypes may modulate the phenotypic manifestation of the deafness-associated 12S rRNA 1555A>G mutation. , 2010, Mitochondrion.

[45]  E. Selimoğlu,et al.  Aminoglycoside-induced ototoxicity. , 2007, Current pharmaceutical design.

[46]  M. Sarkar,et al.  Bmc Ear, Nose and Throat Disorders Open Access Audiologic Monitoring of Multi-drug Resistant Tuberculosis Patients on Aminoglycoside Treatment with Long Term Follow-up , 2007 .

[47]  K. Vrana,et al.  Treatment of Infectious Diseases , 2007 .

[48]  S. Claes,et al.  Non-Syndromic Deafness Associated with a Mutation and a Polymorphism in the Mitochondrial 12S Ribosomal RNA Gene in a Large Zairean Pedigree , 1996, European journal of human genetics : EJHG.